Benzinga | Aug 5, 2021 05:15PM EDT

Guardant Health Q2 EPS $(0.96) Misses $(0.87) Estimate, Sales $92.10M Beat $84.61M Estimate

Guardant Health (NASDAQ:GH) reported quarterly losses of $(0.96) per share which missed the analyst consensus estimate of $(0.87) by 10.34 percent. This is a 68.42 percent decrease over losses of $(0.57) per share from the same period last year. The company reported quarterly sales of $92.10 million which beat the analyst consensus estimate of $84.61 million by 8.85 percent. This is a 38.84 percent increase over sales of $66.33 million the same period last year.